Clinical Trials Directory

Trials / Completed

CompletedNCT06717672

Effect of Lidocaine in Reducing Opioids Requirement in Day Care Surgery

Efficacy of Lidocaine in Decreasing Perioperative Analgesic Opioids Requirement After Ambulatory Surgery

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Liaquat National Hospital & Medical College · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

1. \*Reduced opioid consumption 2. \*Decreased pain scores 3. \*Fewer opioid-related side effects 4. \*Improved patient satisfaction

Detailed description

Studies have shown that lidocaine can reduce opioid consumption by 20-50% in the perioperative period. Studies have shown that lidocaine can reduce opioid consumption by 20-50% in the perioperative period. By reducing opioid consumption, lidocaine can also decrease the incidence of opioid-related side effects, such as nausea, vomiting, and respiratory depression. Lidocaine's analgesic effects can improve patient satisfaction and reduce anxiety related to pain

Conditions

Interventions

TypeNameDescription
DRUGLidocaine 2% without vessel constrictor1. \_Lidocaine 2% provides rapid and effective local anesthesia for minor surgical procedures, such as biopsies, excisions, and suturing. 2. \_Pain relief\_: Lidocaine 2% has been shown to provide significant pain relief in patients with acute pain, such as post-operative pain, trauma, and burns. 3. \_Reducing pain intensity\_: Lidocaine 2% has been shown to reduce pain intensity by 30-50% in various clinical studies.
DRUGNormal SalineNormal saline used is an iv fluid given for fluid replacement

Timeline

Start date
2023-11-05
Primary completion
2024-05-10
Completion
2024-05-10
First posted
2024-12-05
Last updated
2024-12-10

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06717672. Inclusion in this directory is not an endorsement.